NASDAQ:PRVA - Nasdaq - US74276R1023 - Common Stock - Currency: USD
PRIVIA HEALTH GROUP INC
NASDAQ:PRVA (1/24/2025, 4:02:17 PM)
After market: 22.58 0 (0%)22.58
-0.35 (-1.53%)
The current stock price of PRVA is 22.58 USD. In the past month the price increased by 13.41%. In the past year, price decreased by -1.14%.
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27...
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market...
Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program; $176.6M in Shared Savings Delivered Across 10 Participating ACOs...
As we head into the final months of 2024, economic conditions appear to be improving. The rate of inflation has slowed down nearly to the Fed’s target rate, the central bank has begun lowering interest rates, and the last jobs report showed a surge in employment. In response, Wall Street’s experts are outlining their top investment picks for the coming few years, offering valuable insights for investors. KeyBanc analyst Matthew Gillmor is focusing on healthcare service stocks, a sector that has
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.68 | 81.68B | ||
CVS | CVS HEALTH CORP | 8.59 | 68.65B | ||
LH | LABCORP HOLDINGS INC | 17.06 | 20.58B | ||
DGX | QUEST DIAGNOSTICS INC | 17.57 | 17.33B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.66 | 14.45B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 171.68 | 14.05B | ||
DVA | DAVITA INC | 19.18 | 13.96B | ||
CHE | CHEMED CORP | 24.05 | 8.25B | ||
HIMS | HIMS & HERS HEALTH INC | 70.16 | 6.74B | ||
CRVL | CORVEL CORP | 24.23 | 5.86B | ||
GH | GUARDANT HEALTH INC | N/A | 5.83B | ||
OPCH | OPTION CARE HEALTH INC | 25.49 | 5.16B |
Privia Health Group, Inc. engages in the provision of healthcare services. The company is headquartered in Arlington, Virginia and currently employs 1,102 full-time employees. The company went IPO on 2021-04-29. The firm collaborates with medical groups, health plans and health systems. The company enhances physician practices, improve patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The platform supports multiple provider types, enables scalable operations, and delivers patient centric in-person and virtual access to care, quality metrics, and lower cost of care. The company provides management services to each Medical Group though a local management services organization.
PRIVIA HEALTH GROUP INC
950 N. Glebe Rd., Suite 700
Arlington VIRGINIA US
CEO: Shawn Morris
Employees: 1102
Company Website: https://www.priviahealth.com/
Investor Relations: http://ir.priviahealth.com/
Phone: 15713668850
The current stock price of PRVA is 22.58 USD.
The exchange symbol of PRIVIA HEALTH GROUP INC is PRVA and it is listed on the Nasdaq exchange.
PRVA stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PRVA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PRVA.
PRVA does not pay a dividend.
The PE ratio for PRVA is 225.8. This is based on the reported non-GAAP earnings per share of 0.1 and the current share price of 22.58 USD.
The outstanding short interest for PRVA is 5.38% of its float.
ChartMill assigns a technical rating of 8 / 10 to PRVA. When comparing the yearly performance of all stocks, PRVA is one of the better performing stocks in the market, outperforming 73.28% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to PRVA. While PRVA has a great health rating, its profitability is only average at the moment.
Over the last trailing twelve months PRVA reported a non-GAAP Earnings per Share(EPS) of 0.1. The EPS increased by -67.74% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.75% | ||
ROA | 1.12% | ||
ROE | 2.09% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 85% to PRVA. The Buy consensus is the average rating of analysts ratings from 29 analysts.
For the next year, analysts expect an EPS growth of -29.25% and a revenue growth 3.39% for PRVA